Optimal investment in HIV prevention programs: more is not always better

Abstract

This paper develops a mathematical/economic framework to address the following question: Given a particular population, a specific HIV prevention program, and a fixed amount of funds that could be invested in the program, how much money should be invested? We consider the impact of investment in a prevention program on the HIV sufficient contact rate (defined via production functions that describe the change in the sufficient contact rate as a function of expenditure on a prevention program), and the impact of changes in the sufficient contact rate on the spread of HIV (via an epidemic model). In general, the cost per HIV infection averted is not constant as the level of investment changes, so the fact that some investment in a program is cost effective does not mean that more investment in the program is cost effective. Our framework provides a formal means for determining how the cost per infection averted changes with the level of expenditure. We can use this information as follows: When the program has decreasing marginal cost per infection averted (which occurs, for example, with a growing epidemic and a prevention program with increasing returns to scale), it is optimal either to spend nothing on the program or to spend the entire budget. When the program has increasing marginal cost per infection averted (which occurs, for example, with a shrinking epidemic and a prevention program with decreasing returns to scale), it may be optimal to spend some but not all of the budget. The amount that should be spent depends on both the rate of disease spread and the production function for the prevention program. We illustrate our ideas with two examples: that of a needle exchange program, and that of a methadone maintenance program.

Modeling the impact of comorbidity on breast cancer patient outcomes

“…Given the complexity of the biological, behavioral, and epidemiological factors, modeling-informed policy serves to convey achievements, shortcomings, and challenges [10]. For the field, the outcomes of these and other statistical modeling research can offer extensive insight into policy modeling and inform policymakers.…”

Assessing the efficiency of mother-to-child HIV prevention in low- and middle-income countries using data envelopment analysis

“…According to Marseille et al [45] the assumption of constant unit costs in the context of HIV prevention may result in substantial inaccuracies as they found compelling evidence that efficiency increased (unit costs decreased) with scale, across all countries and interventions examined. Brandeau et al [5] and Brandeau and Zaric [46], also discuss the issue of scale in HIV prevention programmes, pointing out that the relationship between investment in HIV prevention and HIV infections averted may not be linear, which indicates that increased spending on a prevention programme may not always be cost effective. Our choice of a VRS assumption is also consistent with the publication of Hollingsworth and Smith [47], which warns that when ratios are used, as is the case of the variable political stability, the BCC formulation [18] should be adopted.…”

When Are Calories Like Furniture? Modeling Service Systems to Improve Health

“…In contrast to the tradition of developing isolated models of individual physiological or financial models of treatment options, systems, modeling and simulation techniques have increasingly been used to address broad health issues, including HIV prevention [1], obesity [7], and healthcare management [16].…”